Prefilled syringes provide a safe, convenient, and more accurate method for drug delivery. They help reduce dosing errors and improve patient compliance compared to traditional vials and syringes. Growing demand for home healthcare and self-administration of biologics are major factors driving the adoption of prefilled syringes.
The Global Prefilled Syringes Market Size is estimated to be valued at US$ 11.93 Mn in 2024 and is expected to exhibit a CAGR of 4.7% over the forecast period 2024 to 2030.
Key Takeaways
Key players operating in the prefilled syringes market are The Kraft Heinz Company, Starbucks Coffee Company, The J.M. Smucker Company, Luigi Lavazza SPA, Nestle SA, The Coca-Cola Company, JAB Holding Company, Tata Global Beverages, Tchibo GmbH, and Strauss Group Ltd. These players are undertaking strategic initiatives such as new product launches, expansions, and collaborations to strengthen their market position. For instance, The Kraft Heinz Company acquired a manufacturing plant in China to expand its production capacity.
The rising prevalence of chronic diseases and increasing patient preference for self-injectable drug delivery systems are fueling demand for prefilled syringes. According to the World Health Organization, chronic diseases accounted for 60% of all deaths globally in 2020. Moreover, the growth of in-home healthcare is enabling self-administration of drugs and biologics, thus driving prefilled syringe adoption.
Technological advancements in prefilled syringe design are also boosting the market. Smart prefilled syringes embedded with sensors can track usage data and support digital therapeutics. Disposable autodisable prefilled syringes provide enhanced safety by preventing needlestick injuries and re-use.
Market Trends
Single-dose prefilled syringes are increasingly replacing multi-dose vials due to lower risks of contamination. They help ensure drug integrity from manufacture until administration. Emerging biosimilars also present lucrative opportunities due to their potential for high-volume prefilled syringe production.
Customizable prefilled syringes with on-body delivery systems are gaining interest in chronic diseases like diabetes. Combination products comprising connected prefilled syringes and digital therapeutics can personalize treatment regimes and facilitate remote monitoring.
Market Opportunities
The biologics subsegment is expected to grow at the fastest pace owing to increasing demand for self-injectable biologic drugs in chronic inflammatory diseases like arthritis. Partnerships between device makers and pharmaceutical firms can accelerate the development of specialized prefilled syringes for biologics.
In emerging markets, improving access to healthcare infrastructure and patient affordability present large opportunities. Local production of affordable prefilled syringes can cater to these regions.
Impact of COVID-19 on Prefilled Syringes Market Growth
The outbreak of COVID-19 has impacted the growth of prefilled syringes market significantly. During the initial stages of pandemic in 2020, majority of the hospitals and healthcare facilities shifted their focus towards handling rising COVID-19 cases. This negatively impacted the demand for prefilled syringes from other therapeutic areas like diabetes, autoimmune disorders, cardiovascular diseases and oncology. Temporary lockdowns imposed by various governments hindered the supply chain of prefilled syringes and disrupted production activities. However, as COVID-19 vaccines became available in late 2020 and 2021, the demand for prefilled syringes increased tremendously as they are crucial for large scale manufacturing and administration of vaccines. Prefilled syringes allow for faster vaccination compared to vials as they limit the wastage of doses. Many pharmaceutical companies upgraded their production facilities to meet the unexpected spike in demand for prefilled syringes from vaccine manufacturers. It is expected that widespread vaccination programmes will continue to drive the growth of prefilled syringes market post pandemic as booster doses may be required annually or biannually.
Europe accounts for the largest share of prefilled syringes market in terms of value. Countries like Germany, United Kingdom, France and Italy have well-established healthcare infrastructure and premium pharmaceutical manufacturing facilities. Presence of leading prefilled syringe manufacturers like Gerresheimer, Schott and Nipro cater to the large demand from the region. Asia Pacific is the fastest growing market for prefilled syringes driven by factors like rising healthcare spending, growing generic drug manufacturing sector in India and China, and increasing adoption of self-injection devices. Countries like India, South Korea and China are witnessing substantial investments by global pharmaceutical companies towards expansion of prefilled syringe production capabilities.
Regional Distribution of Prefilled Syringes Market
The prefilled syringes market in North America region is concentrated in United States. The US contributes more than 80% of the total market value due to large pharmaceutical manufacturing base and availability of advanced healthcare facilities. Prefilled syringes are highly preferred for self-administration of drugs across therapeutic areas like diabetes, rheumatoid arthritis and cancer in outpatient settings in the US. Local production and imports from European manufacturers like Gerresheimer and Schott cater to the burgeoning demand.
Get More Insights on This Topic: https://www.pressreleasebulletin.com/prefilled-syringes-market-size-share-and-growth-forecast-2024-2030/
